These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27747259)

  • 21. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
    Zitser J; Peretz C; Ber David A; Shabtai H; Ezra A; Kestenbaum M; Brozgol M; Rosenberg A; Herman T; Balash Y; Gadoth A; Thaler A; Stebbins GT; Goetz CG; Tilley BC; Luo ST; Liu Y; Giladi N; Gurevich T
    Parkinsonism Relat Disord; 2017 Dec; 45():7-12. PubMed ID: 28965872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
    Martinez-Martin P; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    J Neurol; 2013 Jan; 260(1):228-36. PubMed ID: 22865238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS).
    Goetz CG; Stebbins GT; Chmura TA; Fahn S; Poewe W; Tanner CM
    Mov Disord; 2010 Jul; 25(9):1190-4. PubMed ID: 20629138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale.
    Cubo E; Luo S; Martínez-Martín P; Stebbins GT; Lin J; Choi D; García-Bustillo A; Mir P; Santos-Garcia D; Serrano-Dueñas M; Rodriguez-Violante M; Singer C;
    Mov Disord Clin Pract; 2023 Apr; 10(4):586-595. PubMed ID: 37071078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which dyskinesia scale best detects treatment response?
    Goetz CG; Stebbins GT; Chung KA; Hauser RA; Miyasaki JM; Nicholas AP; Poewe W; Seppi K; Rascol O; Stacy MA; Nutt JG; Tanner CM; Urkowitz A; Jaglin JA; Ge S
    Mov Disord; 2013 Mar; 28(3):341-6. PubMed ID: 23390076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
    Khalil H; Aldaajani ZF; Aldughmi M; Al-Sharman A; Mohammad T; Mehanna R; El-Jaafary SI; Dahshan A; Ben Djebara M; Kamel WA; Amer HA; Farghal M; Abdulla F; Al-Talai N; Snineh MA; Farhat N; Jamali FA; Matar RK; Abdelraheem HS; Ghonimi NAM; Al-Melh MA; Elbhrawy S; Alotaibi MS; Elaidy SA; Almuammar SA; Al-Hashel JY; Gouider R; Samir H; Mhiri C; Skorvanek M; Lin J; Martinez-Martin P; Stebbins GT; Luo S; Goetz CG; Bajwa JA
    Mov Disord; 2022 Apr; 37(4):826-841. PubMed ID: 35218056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender-, age-, and race/ethnicity-based differential item functioning analysis of the movement disorder society-sponsored revision of the Unified Parkinson's disease rating scale.
    Goetz CG; Liu Y; Stebbins GT; Wang L; Tilley BC; Teresi JA; Merkitch D; Luo S
    Mov Disord; 2016 Dec; 31(12):1865-1873. PubMed ID: 27943473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimal clinically important difference for the historic parts of the Unified Dyskinesia Rating Scale.
    Makkos A; Kovács M; Pintér D; Janszky J; Kovács N
    Parkinsonism Relat Disord; 2019 Jan; 58():79-82. PubMed ID: 30174275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
    Colosimo C; Martínez-Martín P; Fabbrini G; Hauser RA; Merello M; Miyasaki J; Poewe W; Sampaio C; Rascol O; Stebbins GT; Schrag A; Goetz CG
    Mov Disord; 2010 Jul; 25(9):1131-42. PubMed ID: 20310033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale.
    Yu RL; Wu RM; Chan AY; Mok V; Wu YR; Tilley BC; Luo S; Wang L; LaPelle NR; Stebbins GT; Goetz CG
    Mov Disord Clin Pract; 2017; 4(1):68-77. PubMed ID: 28345011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It Is as It Was: MDS-UPDRS Part III Scores Cannot Be Combined with Other Parts to Give a Valid Sum.
    Goetz CG; Choi D; Guo Y; Stebbins GT; Mestre TA; Luo S
    Mov Disord; 2023 Feb; 38(2):342-347. PubMed ID: 36480107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.
    Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease
    Mov Disord; 2003 Jul; 18(7):738-50. PubMed ID: 12815652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Movement disorder society unified Parkinson disease rating scale experiences in daily living: longitudinal changes and correlation with other assessments.
    Lang AE; Eberly S; Goetz CG; Stebbins G; Oakes D; Marek K; Ravina B; Tanner CM; Shoulson I;
    Mov Disord; 2013 Dec; 28(14):1980-6. PubMed ID: 24123383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How Efficient Is Subthalamic Deep Brain Stimulation in Reducing Dyskinesia in Parkinson's Disease?
    Juhász A; Deli G; Aschermann Z; Janszky J; Harmat M; Makkos A; Kovács M; Komoly S; Balás I; Dóczi T; Büki A; Kovács N
    Eur Neurol; 2017; 77(5-6):281-287. PubMed ID: 28391276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
    Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
    Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease.
    Raciti L; Nicoletti A; Mostile G; Bonomo R; Dibilio V; Donzuso G; Sciacca G; Cicero CE; Luca A; Zappia M
    Neurol Sci; 2019 Jun; 40(6):1271-1273. PubMed ID: 30737581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-Home Remote Assessment of the MDS-UPDRS Part III: Multi-Cultural Development and Validation of a Guide for Patients.
    Tosin MHS; Sanchez-Ferro A; Wu RM; de Oliveira BGRB; Leite MAA; Suárez PR; Goetz CG; Martinez-Martin P; Stebbins GT; Mestre TA
    Mov Disord Clin Pract; 2024 Sep; ():. PubMed ID: 39310988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unified Parkinson's disease rating scale motor examination: are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable?
    Post B; Merkus MP; de Bie RM; de Haan RJ; Speelman JD
    Mov Disord; 2005 Dec; 20(12):1577-84. PubMed ID: 16116612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile.
    Goetz CG; Nutt JG; Stebbins GT
    Mov Disord; 2008 Dec; 23(16):2398-403. PubMed ID: 19025759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.